Navigation Links
New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
Date:9/30/2013

New York, NY (PRWEB) September 30, 2013

China’s newly diagnosed female breast cancer patients are expected to outnumber those in the United States for the first time in 2015, according to new data from Kantar Health’s CancerMPact® Patient Metrics – Expanded Markets. The number of newly diagnosed women in China is expected to continue to increase to more than 300,000 per year by 2040.

The number of breast cancer patients diagnosed annually has increased by over 50 percent since 2004. In 2012 China had 225,000 new cases of breast cancer, compared with 149,000 in 2004. In the U.S., the number of patients newly diagnosed with breast cancer increased by only 17 percent over this same period. Incidence of breast cancer is still much higher in China’s urban population than in rural areas, but the rural incidence rate has been growing faster in recent years, narrowing the gap between urban and rural areas. In addition, the mean age of diagnosis of breast cancer is approximately nine years younger in China than it is in the U.S. or Europe.

These data were drawn from CancerMPact® Patient Metrics – Expanded Markets, which builds upon Kantar Health's gold-standard epidemiology for the G7 markets by combining epidemiologic data and analysis to estimate incidence by stage, five-year prevalence and treatable patients in 10 tumor types in Argentina, Brazil, Canada, China, India, Mexico, Russia, South Korea, Taiwan and Turkey:

  •     Breast
  •     Colorectal
  •     Gastric
  •     Hepatocellular carcinoma
  •     Multiple myeloma
  •     Non-Hodgkin’s lymphoma
  •     Non-small cell lung
  •     Ovarian
  •     Pancreatic
  •     Prostate

“Historically, China has had one of the lowest incidence rates of breast cancer, especially when compared with Western countries,” said David Robinson, Vice President, Kantar Health. “However, incidence has risen much more quickly over the past two decades than it has in other countries, mainly due to the general aging of the population and increased adoption of Westernized diets. Our data suggest that these factors will likely lead to continued increases in incidence.”

About CancerMPact®
CancerMPact® is an invaluable oncology decision support resource for market analysis, strategic planning and identification of commercial opportunities in the U.S., Western Europe, Japan and China. This resource is composed of web-based integrated modules: Treatment Practices and Evolution (Treatment Architecture and Future Trends and Insights) and Patient Metrics (Patient Metrics – G7, Patient Metrics – Expanded Markets and Biomarker Analysis).

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11169194.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
2. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
3. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
4. Kantar Health Launches CancerMPact Biomarker Analysis
5. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
6. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
7. Kantar Health to Present at PBIRG Annual General Meeting
8. AACR honors Hagop Kantarjian for outstanding clinical research
9. Kantar Health to Participate in CIO Summit of America Conference
10. Kantar Health Further Strengthens Its Advanced Methods and Client Consulting Capabilities in the UK
11. In-Depth Health Claim Review Saves Client Up to $15,000 on Surgery that Fails to Meet Standards for Medical Necessity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors in ... School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green Hospital ... at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train in ...
(Date:6/25/2016)... ... , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department ... in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at ... Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
Breaking Medicine Technology: